Sun Radiopharma (formerly Pharmalucence)

Billerica,  MA 
United States
http://www.sunradiopharma.com
  • Booth: 101


Come see us at Booth 101!

Sun Radiopharma (formerly Pharmalucence), a Sun Pharma company, is a New England based parenteral drug manufacturer specializing in aseptic liquid and lyophilized fill and finish for Nuclear Medicine. We are a fully integrated pharmaceutical manufacturing facility performing comprehensive manufacturing services such as product and process development, analytical method development, commercial scale parenteral fill and finish, quality control, and release and stability testing.  

Our 70,000 square foot manufacturing facility in Billerica Massachusetts is the region’s first drug production facility to utilize automated isolator technology in support of a wide array of needs, providing state of the art compliance capabilities for full commercial scale production for markets worldwide.

We currently manufacture 6 radiopharmaceuticals to service the Nuclear Medicine industry and are gearing up to manufacture other Sun Pharma injectable products as we develop into their U.S. parenteral manufacturing base of operations.​​​​

Founded in 2007, Pharmalucence was acquired by Sun Pharma in July of 2014. Please be sure to come visit us at Booth 101 to learn more about our products and company.

Brands: Sestamibi, Mebrofenin, Pyrophosphate, Sulfur Colloid, MDP and now Mertiatide.


 Products

  • Mertiatide - Now Available!
    Kit for the Preparation of Technetium Tc99m
    Betiatide injection, powder, lyophilized, for solution....

  • Indications and Usage

    Technetium Tc 99m mertiatide is a renal imaging agent for use in the diagnosis of congenital and acquired abnormalities, renal failure, urinary tract obstruction, and calculi in adults and pediatric patients. (See PEDIATRIC USE details in full package insert) It is a diagnostic aid in providing renal function, split function, renal angiograms, and renogram curves for whole kidney and renal cortex.

    • Competitively priced first to market generic of the RLD (Reference Listed Drug)
    • Room temperature storage (15° to 30° C) both before and after reconstitution for use up to 6 hours
    • Available in 5 vial kits (MER05)

    See Website for Important Safety Information

    https://www.pharmalucence.com/service/mertiatide/

For Technical Support with this webpage, please contact support.